Presenilin-1-Derived Circular RNAs: Neglected Epigenetic Regulators with Various Functions in Alzheimer's Disease

被引:3
|
作者
Sanadgol, Nima [1 ]
Amini, Javad [2 ]
Beyer, Cordian [1 ]
Zendedel, Adib [3 ]
机构
[1] RWTH Univ Hosp Aachen, Inst Neuroanat, D-52074 Aachen, Germany
[2] North Khorasan Univ Med Sci, Sch Med, Dept Physiol & Pharmacol, Bojnurd 9414975516, Iran
[3] Univ Basel, Inst Anat, Dept Biomed, CH-4056 Basel, Switzerland
关键词
Alzheimer's disease; PSEN1; circular RNAs; miRNA sponging; in silico analysis; GEO;
D O I
10.3390/biom13091401
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The presenilin-1 (PSEN1) gene is crucial in developing Alzheimer's disease (AD), a progressive neurodegenerative disorder and the most common cause of dementia. Circular RNAs (circRNAs) are non-coding RNA generated through back-splicing, resulting in a covalently closed circular molecule. This study aimed to investigate PSEN1-gene-derived circular RNAs (circPSEN1s) and their potential functions in AD. Our in silico analysis indicated that circPSEN1s (hsa_circ_0008521 and chr14:73614502-73614802) act as sponge molecules for eight specific microRNAs. Surprisingly, two of these miRNAs (has-mir-4668-5p and has-mir-5584-5p) exclusively interact with circPSEN1s rather than mRNA-PSEN1. Furthermore, the analysis of pathways revealed that these two miRNAs predominantly target mRNAs associated with the PI3K-Akt signaling pathway. With sponging these microRNAs, circPSEN1s were found to protect mRNAs commonly targeted by these miRNAs, including QSER1, BACE2, RNF157, PTMA, and GJD3. Furthermore, the miRNAs sequestered by circPSEN1s have a notable preference for targeting the TGF-beta and Hippo signaling pathways. We also demonstrated that circPSEN1s potentially interact with FOXA1, ESR1, HNF1B, BRD4, GATA4, EP300, CBX3, PRDM9, and PPARG proteins. These proteins have a prominent preference for targeting the TGF-beta and Notch signaling pathways, where EP300 and FOXA1 have the highest number of protein interactions. Molecular docking analysis also confirms the interaction of these hub proteins and A beta 42 with circPSEN1s. Interestingly, circPSEN1s-targeted molecules (miRNAs and proteins) impacted TGF-beta, which served as a shared signaling pathway. Finally, the analysis of microarray data unveiled distinct expression patterns of genes influenced by circPSEN1s (WTIP, TGIF, SMAD4, PPP1CB, and BMPR1A) in the brains of AD patients. In summary, our findings suggested that the interaction of circPSEN1s with microRNAs and proteins could affect the fate of specific mRNAs, interrupt the function of unique proteins, and influence cell signaling pathways, generally TGF-beta. Further research is necessary to validate these findings and gain a deeper understanding of the precise mechanisms and significance of circPSEN1s in the context of AD.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] A presenilin-1 truncating mutation causing Alzheimer's disease
    De Jonghe, C
    Tysoe, C
    Cruts, M
    Vanderhoeven, I
    Vanderstichele, H
    Vanmechelen, E
    Van Broeckhoven, C
    Rubinsztein, DC
    Hendriks, L
    ALZHEIMER'S DISEASE AND RELATED DISORDERS: ETIOLOGY, PATHOGENESIS AND THERAPEUTICS, 1999, : 81 - 86
  • [32] Quantification of presenilin-1 mRNA in Alzheimer's disease brains
    Johnston, JA
    Froelich, S
    Lannfelt, L
    Cowburn, RF
    FEBS LETTERS, 1996, 394 (03) : 279 - 284
  • [33] A presenilin 1 mutation in the first case of Alzheimer's disease: Revisited
    Rupp, Carsten
    Beyreuther, Konrad
    Maurer, Konrad
    Kins, Stefan
    ALZHEIMERS & DEMENTIA, 2014, 10 (06) : 869 - 872
  • [34] CSF Presenilin-1 complexes are increased in Alzheimer’s disease
    María-Salud García-Ayllón
    María-Letizia Campanari
    Gunnar Brinkmalm
    Alberto Rábano
    Jordi Alom
    Carlos A Saura
    Niels Andreasen
    Kaj Blennow
    Javier Sáez-Valero
    Acta Neuropathologica Communications, 1
  • [35] Immunoreactivity of presenilin-1 and tau in Alzheimer's disease brain
    Hendriks, L
    De Jonghe, C
    Lübke, U
    Woodrow, S
    Vanderhoeven, I
    Boons, J
    Cras, P
    Martin, JJ
    Van Broeckhoven, C
    EXPERIMENTAL NEUROLOGY, 1998, 149 (02) : 341 - 348
  • [36] CSF Presenilin-1 complexes are increased in Alzheimer's disease
    Garcia-Ayllon, Maria-Salud
    Campanari, Maria-Letizia
    Brinkmalm, Gunnar
    Rabano, Alberto
    Alom, Jordi
    Saura, Carlos A.
    Andreasen, Niels
    Blennow, Kaj
    Saez-Valero, Javier
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2013, 1
  • [37] A presenilin-1 mutation in a Japanese family with Alzheimer's disease
    Aoki, M
    Abe, K
    Tsuda, T
    Morita, M
    Itoyama, Y
    Oda, N
    Kanai, M
    Watanabe, M
    Shoji, M
    Ikeda, M
    NEUROLOGY, 1997, 48 (03) : 1096 - 1096
  • [39] Pick bodies in a family with presenilin-1 Alzheimer's disease
    Halliday, GM
    Song, YJC
    Lepar, G
    Brooks, WS
    Kwok, JB
    Kersaitis, C
    Gregory, G
    Shepherd, CE
    Rahimi, F
    Schofield, PR
    Kril, JJ
    ANNALS OF NEUROLOGY, 2005, 57 (01) : 139 - 143
  • [40] Circular RNAs in Alzheimer's Disease: A New Perspective of Diagnostic and Therapeutic Targets
    Vakili, Omid
    Asili, Pooria
    Babaei, Zeinab
    Mirahmad, Maryam
    Keshavarzmotamed, Atoosa
    Asemi, Zatollah
    Mafi, Alireza
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2023, 22 (09) : 1335 - 1354